It is a common chronic liver disease linked to obesity, type 2 diabetes, and cardiometabolic risks. It encompasses conditions like isolated steatosis (MASL), steatohepatitis (MASH), fibrosis, and cirrhosis. MASLD increases the risk of diabetes, heart disease, and certain cancers, and it is crucial to manage associated conditions to prevent progression.
Type 2 diabetes can lead to chronic kidney disease if not properly managed over time. This condition can damage the blood vessels in the kidneys, which are responsible for filtering waste from the blood. One serious complication that can arise from both type 1 and type 2 diabetes is diabetic nephropathy. This occurs when the kidneys gradually lose their ability to filter waste effectively. To help prevent or slow the progression of diabetic nephropathy, it is essential to maintain healthy blood pressure and blood glucose levels.
Thyroid eye disease (TED) is an inflammatory disorder that affects the tissues around your eyes, causing swelling, discomfort, and other symptoms. It occurs in some individuals with autoimmune diseases that target their thyroid gland. Most often, it happens in people who have Graves’ disease. In this case, your healthcare provider may refer to it as Graves’ eye disease.
Chronic respiratory symptoms and airflow limitation are key characteristics of progressive lung disease. This includes conditions like emphysema and chronic bronchitis, which cause irreversible damage to the airways and lead to difficulties in breathing. The primary cause of these conditions is prolonged exposure to irritants that harm the lungs, such as cigarette smoke and air pollution.
A condition where the airways become narrow, swollen, and produce excess mucus. This can lead to difficulty breathing, trigger coughing, cause a whistling sound (wheezing) during exhalation, and result in shortness of breath.
MRI-PDFF is a quantitative imaging biomarker that enables the accurate, repeatable, and reproducible assessment of liver fat over the entire liver. MRI-PDFF is emerging as one of the leading non-invasive quantitative biomarkers.
Multiple Sclerosis (MS) is a chronic autoimmune disorder that impacts the central nervous system. In this condition, the immune system mistakenly attacks the protective covering of nerve cells, called myelin. This damage disrupts communication between the brain and the rest of the body, leading to a variety of symptoms such as muscle weakness, changes in vision, numbness, and memory problems.